ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,552,802, issued on Feb. 17, was assigned to Merck Sharpe & Dohme LLC (Rahway, N.J.).
"Fused [7,5 bicyclic pyrazole derivatives and methods of use thereof for the treatment of herpesviruses" was invented by Andrew J. Cooke Jr. (Doylestown, Pa.), Jeffrey W. Schubert (North Wales, Pa.) and Jason W. Skudlarek (Audubon, Pa.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to novel Fused [7,5] Bicyclic Pyrazole Derivatives of Formula (I): (I) and pharmaceutically acceptable salts thereof, wherein X, R1, R2, R3, and R4 are as defined herein. The present invention also relates to compositions comprising at least one Fused [7,5] Bicyc...